Daptomycin activity tested against linezolid-nonsusceptible gram-positive clinical isolates

Microbial Drug Resistance

Volumn 15, Issue 4, 2009, Pages 245-249

  Mendes, Rodrigo E ^a   Jones, Ronald N ^a,b   Deshpande, Lalitagauri M ^a   Ross, James E ^a   Sader, Hélio S ^a,c  

^a JMI LABORATORIES   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; DAPTOMYCIN; LINEZOLID; RIBOSOME RNA;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; ENTEROCOCCUS; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS;

ACETAMIDES; ANTI-BACTERIAL AGENTS; DAPTOMYCIN; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; MICROBIAL SENSITIVITY TESTS; MUTATION; OXAZOLIDINONES; RNA, BACTERIAL; RNA, RIBOSOMAL, 23S; STAPHYLOCOCCUS;

ENTEROCOCCUS; POSIBACTERIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 70350438393     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2009.0045     Document Type: Article

References (19)

1. Castanheira, M., R.N. Jones, and H.S. Sader. 2008. Update of the in vitro activity of daptomycin tested against 6710 Gram-positive cocci isolated in North America (2006). Diagn. Microbiol. Infect. Dis. 61:235-239.
2. CLSI. 2006. M7-A7, methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-seventh edition Clinical and Laboratory Standards Institute. Wayne, PA.
3. CLSI. 2008. M100-S18, Performance standards for antimicrobial susceptibility testing, 18th informational supplement Clinical and Laboratory Standards Institute. Wayne, PA.
4. Cosgrove, S.E., and V.G. Fowler, Jr. 2008. Management of methicillin-resistant Staphylococcus aureus bacteremia. Clin. Infect. Dis. 46 Suppl 5:S386-S393.
5. Cubicin (Package Insert). August 2008. Cubist Pharmaceuticals, Inc. Available at www.cubicin.com=pdf= PrescribingInformation.pdf, accessed June 2009. (Online.)
6. Jones, R.N. 2008. Key considerations in the treatment of complicated staphylococcal infections. Clin. Microbiol. Infect. 14 Suppl 2:3-9.
7. Jones, R.N., J.E. Ross, M. Castanheira, and R.E. Mendes. 2008. United States resistance surveillance results for linezolid (LEADER Program for 2007). Diagn. Microbiol. Infect. Dis. 62:416-426.
8. Long, K.S., J. Poehlsgaard, C. Kehrenberg, S. Schwarz, and B. Vester. 2006. The Cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A antibiotics. Antimicrob. Agents Chemother. 50:2500-2505.
9. Marshall, S.H., C.J. Donskey, R. Hutton-Thomas, R.A. Salata, and L.B. Rice. 2002. Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob. Agents Chemother. 46:3334-3336.
10. Meka, V.G., and H.S. Gold. 2004. Antimicrobial resistance to linezolid. Clin. Infect. Dis. 39:1010-1015.
11. Mendes, R.E., L.M. Deshpande, M. Castanheira, J. DiPersio, M.A. Saubolle, and R.N. Jones. 2008. First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States. Antimicrob. Agents Chemother. 52:2244-2246.
12. Naber, C.K. 2008. Future strategies for treating Staphylococcus aureus bloodstream infections. Clin. Microbiol. Infect. 14 Suppl 2:26-34.
13. NNIS. 2004. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004. Am. J. Infect. Control 32:470-485.
14. Sander, P., L. Belova, Y.G. Kidan, P. Pfister, A.S. Mankin, and E.C. Bottger. 2002. Ribosomal and non-ribosomal resistance to oxazolidinones: species-specific idiosyncrasy of ribosomal alterations. Mol. Microbiol. 46:1295-1304.
15. Shorr, A.F. 2007. Epidemiology of staphylococcal resistance. Clin. Infect. Dis. 45 Suppl 3:S171-S176.
16. Stryjewski, M.E., and H.F. Chambers. 2008. Skin and softtissue infections caused by community-acquired methicillinresistant Staphylococcus aureus. Clin. Infect. Dis. 46 Suppl 5:S368-S377.
17. Toh, S.M., L. Xiong, C.A. Arias, M.V. Villegas, K. Lolans, J. Quinn, and A.S. Mankin. 2007. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid. Mol. Microbiol. 64:1506-1514.
18. Wisplinghoff, H., T. Bischoff, S.M. Tallent, H. Seifert, R.P. Wenzel, and M.B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317.
19. Wolter, N., A.M. Smith, D.J. Farrell, W. Schaffner, M. Moore, C.G. Whitney, J.H. Jorgensen, and K.P. Klugman. 2005. Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus. Antimicrob. Agents Chemother. 49: 3554-3557.